STEPHANIE NIEMI-OLSON: Open Payments
NPI 1699191072 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,401 in 53 payments from 17 companies in 2025. Trend: 2023 $1,577 · 2024 $2,219 · 2025 $6,401
Speaker / faculty: $3,863Food & beverage: $2,539
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 14 | $4,591 |
| Novartis Pharmaceuticals Corporation | 3 | $279 |
| Alexion Pharmaceuticals, Inc. | 2 | $237 |
| ABBVIE INC. | 8 | $203 |
| PFIZER INC. | 4 | $190 |
| EMD Serono, Inc. | 3 | $178 |
| Amgen Inc. | 2 | $130 |
| GENZYME CORPORATION | 2 | $125 |
| Biogen, Inc. | 2 | $101 |
| Vanda Pharmaceuticals Inc. | 3 | $87 |
Products named: BRIUMVI, KESIMPTA, ULTOMIRIS, BOTOX, ZAVZPRET, UPLIZNA, PONVORY, NURTEC ODT.
Industry payments across AZ — which companies pay providers there.
